User profiles for Daniel E Abbott
 | Daniel AbbottAssociate Professor of Surgery, University of Wisconsin Verified email at surgery.wisc.edu Cited by 9670 |
Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology
AB Benson, MI D'Angelica, DE Abbott… - Journal of the National …, 2021 - jnccn.org
The NCCN Guidelines for Hepatobiliary Cancers focus on the screening, diagnosis, staging,
treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and …
treatment, and management of hepatocellular carcinoma (HCC), gallbladder cancer, and …
NCCN guidelines insights: hepatobiliary cancers, version 1.2017
AB Benson, MI D'Angelica, DE Abbott… - Journal of the National …, 2017 - jnccn.org
The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for
cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets …
cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets …
Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells
…, A Lipavsky, WW Wheaton, DE Abbott… - Proceedings of the …, 2008 - National Acad Sciences
Embryonic stem cells sustain a microenvironment that facilitates a balance of self-renewal
and differentiation. Aggressive cancer cells, expressing a multipotent, embryonic cell-like …
and differentiation. Aggressive cancer cells, expressing a multipotent, embryonic cell-like …
NCCN guidelines insights: Hepatobiliary cancers, version 2.2019: Featured updates to the NCCN guidelines
AB Benson, MI D'Angelica, DE Abbott… - Journal of the National …, 2019 - jnccn.org
The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for
cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets …
cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets …
A multi-institutional comparison of perioperative outcomes of robotic and open pancreaticoduodenectomy
Objectives: Limited data exist comparing robotic and open approaches to pancreaticoduodenectomy
(PD). We performed a multicenter comparison of perioperative outcomes of robotic …
(PD). We performed a multicenter comparison of perioperative outcomes of robotic …
Risk factors and consequences of anastomotic leak after colectomy: a national analysis
BACKGROUND: Previous research has identified a number of patient and operative factors
associated with anastomotic leak after colectomy; however, a study that examines these …
associated with anastomotic leak after colectomy; however, a study that examines these …
Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival
Barriers to multimodality therapy (MMT) completion among patients with resectable pancreatic
adenocarcinoma include early cancer progression and postoperative major complications …
adenocarcinoma include early cancer progression and postoperative major complications …
NCCN guidelines® Insights: biliary tract cancers, version 2.2023: featured updates to the NCCN guidelines
…, MI D'Angelica, T Abrams, DE Abbott… - Journal of the National …, 2023 - jnccn.org
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines:
Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary …
Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary …
Effect of hospital safety-net burden on cost and outcomes after surgery
…, DJ Weilage, DJ Hanseman, DE Abbott… - JAMA …, 2016 - jamanetwork.com
Importance Safety-net hospitals provide broad services for a vulnerable population of
patients and are financially at risk owing to impending reimbursement penalties and policy …
patients and are financially at risk owing to impending reimbursement penalties and policy …
Survival outcomes associated with clinical and pathological response following neoadjuvant FOLFIRINOX or gemcitabine/nab-paclitaxel chemotherapy in resected …
Objective: To compare the survival outcomes associated with clinical and pathological
response in pancreatic ductal adenocarcinoma (PDAC) patients receiving neoadjuvant …
response in pancreatic ductal adenocarcinoma (PDAC) patients receiving neoadjuvant …
